On the public citation graph

Retention of patients in opioid substitution treatment: A systematic review

https://doi.org/10.1371/journal.pone.0232086
0 signed · 407 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.
Claim with ORCID
Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.
See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/14651858.cd002207.pub2openalex-snapshot
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
inferredcites →https://doi.org/10.1002/14651858.cd002207.pub4openalex-snapshot
Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence
inferredcites →https://doi.org/10.1002/14651858.cd002209openalex-snapshot
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
inferredcites →https://doi.org/10.1002/14651858.cd002209.pub2openalex-snapshot
Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence
inferredcites →https://doi.org/10.1002/14651858.cd007775.pub2openalex-snapshot
Pharmacological therapies for maintenance treatments of opium dependence
inferredcites →https://doi.org/10.1002/14651858.cd011117openalex-snapshot
Opioid agonist treatment for pharmaceutical opioid dependent people
inferredcites →https://doi.org/10.1002/14651858.cd011117.pub2openalex-snapshot
Opioid agonist treatment for pharmaceutical opioid dependent people
inferredcites →https://doi.org/10.1007/bf02287327openalex-snapshot
Retention in publicly funded methadone maintenance treatment in two western states
inferredcites →https://doi.org/10.1016/j.addbeh.2004.09.004openalex-snapshot
Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence
inferredcites →https://doi.org/10.1016/j.addbeh.2013.09.001openalex-snapshot
Retention in methadone maintenance treatment in mainland China, 2004–2012: A literature review
inferredcites →https://doi.org/10.1016/j.addbeh.2014.05.007openalex-snapshot
Factors associated with dropout among patients in opioid maintenance treatment (OMT) and predictors of re-entry. A national registry-based study
inferredcites →https://doi.org/10.1016/j.addbeh.2018.09.010openalex-snapshot
Trauma treatment for veterans in buprenorphine maintenance treatment for opioid use disorder
inferredcites →https://doi.org/10.1016/j.addbeh.2018.10.046openalex-snapshot
Injection opioid use as a predictor of treatment outcomes among methadone-maintained opioid-dependent patients
inferredcites →https://doi.org/10.1016/j.biopsych.2019.06.020openalex-snapshot
Medication Treatment of Opioid Use Disorder
inferredcites →https://doi.org/10.1016/j.cpr.2013.07.007openalex-snapshot
Drop-out from addiction treatment: A systematic review of risk factors
inferredcites →https://doi.org/10.1016/j.drugalcdep.2005.05.010openalex-snapshot
Cycling in and out of treatment; participation in methadone treatment in NSW, 1990–2002
inferredcites →https://doi.org/10.1016/j.drugalcdep.2009.05.021openalex-snapshot
Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved
inferredcites →https://doi.org/10.1016/j.drugalcdep.2010.09.024openalex-snapshot
Behavioral drug and HIV risk reduction counseling (BDRC) in MMT programs in Wuhan, China: A pilot randomized clinical trial
inferredcites →https://doi.org/10.1016/j.drugalcdep.2011.01.008openalex-snapshot
Predictors of methadone treatment retention from a multi-site study: A survival analysis
inferredcites →https://doi.org/10.1016/j.drugalcdep.2012.12.008openalex-snapshot
Integrating buprenorphine maintenance therapy into federally qualified health centers: Real-world substance abuse treatment outcomes
inferredcites →https://doi.org/10.1016/j.drugalcdep.2013.04.006openalex-snapshot
Benzodiazepine use during buprenorphine treatment for opioid dependence: Clinical and safety outcomes
inferredcites →https://doi.org/10.1016/j.drugalcdep.2013.06.021openalex-snapshot
Time to first treatment interruption in the Chinese methadone maintenance treatment programme
inferredcites →https://doi.org/10.1016/j.drugalcdep.2014.09.776openalex-snapshot
Retention and its predictors among methadone maintenance treatment clients in China: A six-year cohort study
inferredcites →https://doi.org/10.1016/j.drugalcdep.2016.12.009openalex-snapshot
J-shaped relationship between supervised methadone consumption and retention in methadone maintenance treatment (MMT) in primary care: National cohort study
inferredcites →https://doi.org/10.1016/j.drugalcdep.2017.11.034openalex-snapshot
Similarities and changes between 15- and 24-year survival and retention rates of patients in a large medical-affiliated methadone maintenance treatment (MMT) center
inferredcites →https://doi.org/10.1016/j.drugalcdep.2018.08.024openalex-snapshot
Three-year retention in methadone opioid agonist treatment: A survival analysis of clients by dose, area deprivation, and availability of alcohol and cannabis outlets
inferredcites →https://doi.org/10.1016/j.drugalcdep.2019.05.026openalex-snapshot
Stress, craving and mood as predictors of early dropout from opioid agonist therapy
inferredcites →https://doi.org/10.1016/j.drugpo.2017.05.014openalex-snapshot
Retention in medication-assisted treatment programs in Ukraine—Identifying factors contributing to a continuing HIV epidemic
inferredcites →https://doi.org/10.1016/j.ejpain.2008.04.011openalex-snapshot
Clinical update on the pharmacology, efficacy and safety of transdermal buprenorphine
inferredcites →https://doi.org/10.1016/j.jsat.2005.02.007openalex-snapshot
An overview of systematic reviews of the effectiveness of opiate maintenance therapies: available evidence to inform clinical practice and research
inferredcites →https://doi.org/10.1016/j.jsat.2011.05.001openalex-snapshot
Risk of drug-related mortality during periods of transition in methadone maintenance treatment: A cohort study
inferredcites →https://doi.org/10.1016/j.jsat.2011.07.009openalex-snapshot
Predictive factors for treatment retention in methadone programs in Indonesia
inferredcites →https://doi.org/10.1016/j.jsat.2012.03.002openalex-snapshot
Predictors of methadone program non-retention for opioid analgesic dependent patients
inferredcites →https://doi.org/10.1016/j.jsat.2013.08.012openalex-snapshot
Web-based behavioral treatment for substance use disorders as a partial replacement of standard methadone maintenance treatment
inferredcites →https://doi.org/10.1016/j.jsat.2013.10.004openalex-snapshot
Leaving buprenorphine treatment: Patients' reasons for cessation of care
inferredcites →https://doi.org/10.1016/j.jsat.2015.04.010openalex-snapshot
Prior Experience with Non-Prescribed Buprenorphine: Role in Treatment Entry and Retention
inferredcites →https://doi.org/10.1016/j.jsat.2016.12.010openalex-snapshot
Long-term retention in Office Based Opioid Treatment with buprenorphine
inferredcites →https://doi.org/10.1016/j.jsat.2017.06.004openalex-snapshot
A naturalistic study of predictors of retention in treatment among emerging adults entering first buprenorphine maintenance treatment for opioid use disorders
inferredcites →https://doi.org/10.1016/j.neuropharm.2019.04.015openalex-snapshot
Progress in agonist therapy for substance use disorders: Lessons learned from methadone and buprenorphine
inferredcites →https://doi.org/10.1016/j.pnpbp.2010.12.002openalex-snapshot
Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance
inferredcites →https://doi.org/10.1016/s0140-6736(10)60232-2openalex-snapshot
HIV prevention, treatment, and care services for people who inject drugs: a systematic review of global, regional, and national coverage
inferredcites →https://doi.org/10.1016/s0140-6736(98)05356-2openalex-snapshot
Role of maintenance treatment in opioid dependence
inferredcites →https://doi.org/10.1016/s0740-5472(01)00185-4openalex-snapshot
Transportation and retention in outpatient drug abuse treatment programs
inferredcites →https://doi.org/10.1016/s2215-0366(15)00366-1openalex-snapshot
Mortality risk of opioid substitution therapy with methadone versus buprenorphine: a retrospective cohort study
inferredcites →https://doi.org/10.1016/s2215-0366(18)30337-7openalex-snapshot
The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
inferredcites →https://doi.org/10.1037/adb0000090openalex-snapshot
Predictors of patient retention in methadone maintenance treatment.
inferredcites →https://doi.org/10.1038/d41586-019-02682-6openalex-snapshot
Opioids by the numbers
inferredcites →https://doi.org/10.1080/02791072.2006.10399832openalex-snapshot
Predicting Treatment Retention with a Brief “Opinions About Methadone” Scale
inferredcites →https://doi.org/10.1080/02791072.2009.10400535openalex-snapshot
Sense of Coherence as a Stable Predictor for Methadone Maintenance Treatment (MMT) Outcome
inferredcites →https://doi.org/10.1080/02791072.2013.825032openalex-snapshot
Methadone Maintenance Treatment Experience in Macao – Prospective Follow-up for Initial 4.5 Years
inferredcites →https://doi.org/10.1080/09540121.2016.1259452openalex-snapshot
Club drugs and alcohol abuse predicted dropout and poor adherence among methadone maintenance treatment patients in Guangzhou, China
inferredcites →https://doi.org/10.1080/10550880802122620openalex-snapshot
The Impact of Benzodiazepine Use on Methadone Maintenance Treatment Outcomes
inferredcites →https://doi.org/10.1080/10550880802324382openalex-snapshot
One-Year and Cumulative Retention as Predictors of Success in Methadone Maintenance Treatment: A Comparison of Two Clinics in the United States and Israel
inferredcites →https://doi.org/10.1080/10550887.2016.1100960openalex-snapshot
Retention in medication-assisted treatment for opiate dependence: A systematic review
inferredcites →https://doi.org/10.1080/23288604.2018.1440347openalex-snapshot
Association Between User Fees and Dropout from Methadone Maintenance Therapy: Results of a Cohort Study in Vietnam
inferredcites →https://doi.org/10.1093/aje/kwp186openalex-snapshot
Proportional Hazards Frailty Models for Recurrent Methadone Maintenance Treatment
inferredcites →https://doi.org/10.1093/cid/ciu382openalex-snapshot
Methadone Treatment for HIV Prevention--Feasibility, Retention, and Predictors of Attrition in Dar es Salaam, Tanzania: A Retrospective Cohort Study
inferredcites →https://doi.org/10.1093/cid/civ476openalex-snapshot
The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs
inferredcites →https://doi.org/10.1097/adm.0000000000000156openalex-snapshot
Evaluating the Effectiveness of First-Time Methadone Maintenance Therapy Across Northern, Rural, and Urban Regions of Ontario, Canada
inferredcites →https://doi.org/10.1097/adm.0000000000000263openalex-snapshot
Medication Adherence in Patients Undergoing Methadone Maintenance Treatment in Xi’an, China
inferredcites →https://doi.org/10.1097/adm.0b013e31829727b2openalex-snapshot
Prior Buprenorphine Experience Is Associated With Office-Based Buprenorphine Treatment Outcomes
inferredcites →https://doi.org/10.1097/adm.0b013e31829da05bopenalex-snapshot
A Study of 6-Year Retention in Methadone Maintenance Treatment Among Opioid-Dependent Patients in Xi'an
inferredcites →https://doi.org/10.1097/adt.0000000000000099openalex-snapshot
Factor Predictive of 1-Year Retention on Methadone Maintenance Therapy Program: A Survival Analysis Study
inferredcites →https://doi.org/10.1097/mlr.0000000000000727openalex-snapshot
Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
inferredcites →https://doi.org/10.1111/add.12863openalex-snapshot
Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006–10
inferredcites →https://doi.org/10.1111/add.13087openalex-snapshot
Risk of mortality on and off methadone substitution treatment in primary care: a national cohort study
inferredcites →https://doi.org/10.1111/add.14012openalex-snapshot
Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane Review and meta‐analysis
inferredcites →https://doi.org/10.1111/add.14188openalex-snapshot
The impact of buprenorphine and methadone on mortality: a primary care cohort study in the United Kingdom
inferredcites →https://doi.org/10.1111/add.14398openalex-snapshot
High‐intensity cannabis use is associated with retention in opioid agonist treatment: a longitudinal analysis
inferredcites →https://doi.org/10.1111/ajad.12553openalex-snapshot
Three-year retention in buprenorphine treatment for opioid use disorder nationally in the Veterans Health Administration
inferredcites →https://doi.org/10.1111/ajad.12896openalex-snapshot
Long‐Term Retention in an Outpatient Behavioral Health Clinic With Buprenorphine
inferredcites →https://doi.org/10.1111/dar.12608openalex-snapshot
Large variation in measures used to assess outcomes of opioid dependence treatment: A systematic review of longitudinal observational studies
inferredcites →https://doi.org/10.1111/ijpp.12049openalex-snapshot
Does training in motivational interviewing for community pharmacists improve outcomes for methadone patients? A cluster randomised controlled trial
inferredcites →https://doi.org/10.1111/j.1360-0443.2008.02249.xopenalex-snapshot
Key findings from the WHO collaborative study on substitution therapy for opioid dependence and HIV/AIDS
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02538.xopenalex-snapshot
Retention in methadone maintenance drug treatment for prescription‐type opioid primary users compared to heroin users
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02633.xopenalex-snapshot
Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention
inferredcites →https://doi.org/10.1111/j.1360-0443.2009.02754.xopenalex-snapshot
Outcome of long‐term heroin‐assisted treatment offered to chronic, treatment‐resistant heroin addicts in the Netherlands
inferredcites →https://doi.org/10.1111/j.1360-0443.2010.03140.xopenalex-snapshot
Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies
inferredcites →https://doi.org/10.1111/j.1360-0443.2011.03700.xopenalex-snapshot
Randomized trial of standard methadone treatment compared to initiating methadone without counseling: 12‐month findings
inferredcites →https://doi.org/10.1111/j.1360-0443.2012.03859.xopenalex-snapshot
Misconceptions predict dropout and poor adherence prospectively among newly admitted first‐time methadone maintenance treatment clients in Guangzhou, China
inferredcites →https://doi.org/10.1111/j.1525-1497.2005.0228.xopenalex-snapshot
Brief report: Buprenorphine retention in primary care
inferredcites →https://doi.org/10.1136/bmj.b2535openalex-snapshot
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement
inferredcites →https://doi.org/10.1136/bmj.c3172openalex-snapshot
Survival and cessation in injecting drug users: prospective observational study of outcomes and effect of opiate substitution treatment
inferredcites →https://doi.org/10.1136/bmj.c5475openalex-snapshot
Risk of death during and after opiate substitution treatment in primary care: prospective observational study in UK General Practice Research Database
inferredcites →https://doi.org/10.1136/bmj.e5945openalex-snapshot
Opiate substitution treatment and HIV transmission in people who inject drugs: systematic review and meta-analysis
inferredcites →https://doi.org/10.1136/bmj.j1550openalex-snapshot
Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies
inferredcites →https://doi.org/10.1136/bmjopen-2017-017453openalex-snapshot
Consensus validation of the POSAMINO (POtentially Serious Alcohol–Medication INteractions in Older adults) criteria
inferredcites →https://doi.org/10.1159/000368408openalex-snapshot
The Effect of Riding as an Alternative Treatment for Children with Cerebral Palsy: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1176/appi.ps.201700363openalex-snapshot
Three-Year Retention in Buprenorphine Treatment for Opioid Use Disorder Among Privately Insured Adults
inferredcites →https://doi.org/10.1177/1060028017751913openalex-snapshot
Treatment Persistence Among Insured Patients Newly Starting Buprenorphine/Naloxone for Opioid Use Disorder
inferredcites →https://doi.org/10.1185/03007995.2013.796284openalex-snapshot
Trends and predictors in methadone maintenance treatment dropout in Shanghai, China: 2005–2011
inferredcites →https://doi.org/10.1186/1471-244x-12-238openalex-snapshot
Methadone treatments in a Swiss Region, 2001–2008: a registry-based analysis
inferredcites →https://doi.org/10.1186/1477-7517-10-3openalex-snapshot
Predictors of retention in community-based methadone maintenance treatment program in Pearl River Delta, China
inferredcites →https://doi.org/10.1186/s12954-016-0124-zopenalex-snapshot
Retention in Georgia opioid substitution therapy program and associated factors
inferredcites →https://doi.org/10.1186/s12954-017-0134-5openalex-snapshot
The impact of benzodiazepine use in patients enrolled in opioid agonist therapy in Northern and rural Ontario
inferredcites →https://doi.org/10.1186/s13722-017-0072-2openalex-snapshot
Public sector low threshold office-based buprenorphine treatment: outcomes at year 7
inferredcites →https://doi.org/10.1300/j126v03n02_06openalex-snapshot
Determinants of Retention in a Canadian Low-Threshold Methadone Maintenance Program
inferredcites →https://doi.org/10.13140/2.1.1018.4643openalex-snapshot
Guidance on the conduct of narrative synthesis in systematic reviews: A product from the ESRC Methods Programme
inferredcites →https://doi.org/10.1345/aph.1g276openalex-snapshot
Role of Buprenorphine in the Management of Heroin Addiction
inferredcites →https://doi.org/10.1371/journal.pmed.1000097openalex-snapshot
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
inferredcites →https://doi.org/10.1371/journal.pone.0068906openalex-snapshot
Methadone Maintenance Treatment Participant Retention and Behavioural Effectiveness in China: A Systematic Review and Meta-Analysis
inferredcites →https://doi.org/10.1371/journal.pone.0123687openalex-snapshot
Factors Associated with Methadone Treatment Duration: A Cox Regression Analysis
inferredcites →https://doi.org/10.1371/journal.pone.0139942openalex-snapshot
Investigation of Repeat Client Drop-Out and Re-Enrolment Cycles in Fourteen Methadone Maintenance Treatment Clinics in Guangdong, China
inferredcites →https://doi.org/10.1371/journal.pone.0179009openalex-snapshot
Bidirectional relationships between retention and health-related quality of life in Chinese mainland patients receiving methadone maintenance treatment
inferredcites →https://doi.org/10.1517/14656560903037168openalex-snapshot
Opioid dependence treatment: options in pharmacotherapy
inferredcites →https://doi.org/10.3109/00952990.2012.694516openalex-snapshot
A National Study of the Retention of Irish Opiate Users in Methadone Substitution Treatment
inferredcites →https://doi.org/10.3109/10826084.2012.749411openalex-snapshot
Predictors for Dropping-Out From Methadone Maintenance Therapy Programs Among Heroin Users in Southern Taiwan
inferredcites →https://doi.org/10.3109/10826084.2014.957769openalex-snapshot
Psychological Predictors of Retention in a Low-Threshold Methadone Maintenance Treatment for Opioid Addicts: A 1-Year Follow-Up Study
inferredcites →https://doi.org/10.3390/ijerph6112822openalex-snapshot
Impact of Co-Occurring Psychiatric Disorders on Retention in a Methadone Maintenance Program: An 18-Month Follow-Up Study
inferredcites →https://doi.org/10.36076/ppj.2013/16/e739openalex-snapshot
Long-term Consequences of Acute Pain for Patients under Methadone or Buprenorphine Maintenance Treatment
inferredcites →https://doi.org/10.5055/jom.2007.0036openalex-snapshot
Patterns of illicit drug use and retention in a methadone program: A longitudinal study
inferredcites →https://doi.org/10.9778/cmajo.20140089openalex-snapshot
Sex differences in outcomes of methadone maintenance treatment for opioid use disorder: a systematic reviewand meta-analysis

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4093881openalex-extracted
inferred← citeshttps://doi.org/10.2139/ssrn.4199087openalex-extracted
Malmö Treatment Referral and Intervention Study (MATRIS)—36-Month Follow-Up on Retention and Substance Use Among Patients Referred from a Needle Exchange Program to Opioid Substitution Treatment
inferred← citeshttps://doi.org/10.1001/jamainternmed.2026.3904openalex-snapshot
Timing of Initiation of Methadone Take-Home Dosing
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.48405openalex-snapshot
Smartphone App–Based Contingency Management and Opioid Use Disorder Treatment Outcomes
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2024.57976openalex-snapshot
Rest-Activity Rhythms, Their Modulators, and Brain-Clinical Correlates in Opioid Use Disorder
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.53538openalex-snapshot
Opioid Treatment Programs’ Medicaid Patient Retention Rates
inferred← citeshttps://doi.org/10.1001/jamanetworkopen.2025.6069openalex-snapshot
Medication for Opioid Use Disorder and Treatment Retention Among Pregnant Individuals
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2021.0976openalex-snapshot
The impact of opioid agonist treatment delivered in different settings on all-cause mortality and specific causes of death:A systematic review and meta-analysis
inferred← citeshttps://doi.org/10.1001/jamapsychiatry.2022.4020openalex-snapshot
Clinical Trial Design Challenges and Opportunities for Emerging Treatments for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1002/hec.4255openalex-snapshot
The effect of British Columbia's Pharmacare coverage expansion for opioid agonist treatment
inferred← citeshttps://doi.org/10.1002/mpr.1929openalex-snapshot
Retention in treatment and therapeutic adherence: How are these associated with therapeutic success? An analysis using real‐world data
inferred← citeshttps://doi.org/10.1007/978-3-032-03402-1_10openalex-snapshot
Secondary Traumatic Stress and Compassion Satisfaction in Substitution Treatment and Harm Reduction Services
inferred← citeshttps://doi.org/10.1007/s00213-025-06747-5openalex-snapshot
Reduced GIRK expression in midbrain dopamine neurons during prolonged abstinence from fentanyl self-administration
inferred← citeshttps://doi.org/10.1007/s00334-020-00793-zopenalex-snapshot
Middle Neolithic farming of open-air sites in SE France: new insights from archaeobotanical investigations of three wells found at Les Bagnoles (L’Isle-sur-la-Sorgue, Dépt. Vaucluse, France)
inferred← citeshttps://doi.org/10.1007/s10461-021-03452-0openalex-snapshot
Twelve-Month Retention in Opioid Agonist Treatment for Opioid Use Disorder Among Patients With and Without HIV
inferred← citeshttps://doi.org/10.1007/s11414-022-09823-2openalex-snapshot
Social Factors Predict Treatment Engagement in Veterans with PTSD or SUD
inferred← citeshttps://doi.org/10.1007/s11469-023-01098-8openalex-snapshot
The Impact of Longitudinal Substance Use Patterns on the Risk of Opioid Agonist Therapy Discontinuation: A Repeated Measures Latent Class Analysis
inferred← citeshttps://doi.org/10.1007/s11469-023-01213-9openalex-snapshot
Opioid Agonist Maintenance Treatment Outcomes—The OPTIMUS International Consensus Towards Evidence-Based and Patient-Centred Care, an Interim Report
inferred← citeshttps://doi.org/10.1007/s11469-025-01532-zopenalex-snapshot
Mortality and Readmission in Opioid Patients: Associations with Comorbid Disorders and Treatment Adherence
inferred← citeshttps://doi.org/10.1007/s11469-026-01639-xopenalex-snapshot
Cohort Profile: The Austrian National Opioid Agonist Treatment Cohort (OAT-AT)
inferred← citeshttps://doi.org/10.1007/s11757-025-00895-2openalex-snapshot
Efficacy of opioid maintenance in prison settings—how strong is the evidence? A narrative review
inferred← citeshttps://doi.org/10.1007/s11920-024-01524-1openalex-snapshot
Controversies in Assessment, Diagnosis, and Treatment of Kratom Use Disorder
inferred← citeshttps://doi.org/10.1007/s40429-020-00352-6openalex-snapshot
The Impact of Chronic Pain on Opioid Use Disorder Treatment Outcomes
inferred← citeshttps://doi.org/10.1007/s40429-023-00492-5openalex-snapshot
The Use of Ecological Momentary Assessment Methods with People Receiving Medication for Opioid Use Disorder: A Systematic Review
inferred← citeshttps://doi.org/10.1007/s40615-021-01095-4openalex-snapshot
Treatment Outcomes Among Black Adults Receiving Medication for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1016/j.addbeh.2020.106655openalex-snapshot
Long term pre-treatment opioid use trajectories in relation to opioid agonist therapy outcomes among people who use drugs in a Canadian setting
inferred← citeshttps://doi.org/10.1016/j.addbeh.2021.107026openalex-snapshot
Treatment outcomes in individuals diagnosed with comorbid opioid use disorder and Posttraumatic stress disorder: A review
inferred← citeshttps://doi.org/10.1016/j.ajem.2022.02.041openalex-snapshot
Long-term treatment retention of an emergency department initiated medication for opioid use disorder program
inferred← citeshttps://doi.org/10.1016/j.cct.2026.108437openalex-snapshot
Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the treatment of opioid use disorder (TAB) trial: study design and rationale
inferred← citeshttps://doi.org/10.1016/j.conctc.2022.100918openalex-snapshot
Rationale, design, and methodology of a randomized pilot trial of an integrated intervention combining computerized behavioral therapy and recovery coaching for people with opioid use disorder: The OVERCOME study
inferred← citeshttps://doi.org/10.1016/j.dadr.2022.100032openalex-snapshot
Modafinil does not reduce cocaine use in methadone-maintained individuals
inferred← citeshttps://doi.org/10.1016/j.dadr.2022.100062openalex-snapshot
Social determinants of health and emergency department utilization among adults receiving buprenorphine for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.dadr.2022.100106openalex-snapshot
Hospitalist perspectives on buprenorphine treatment for inpatients with opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2019.05.026openalex-snapshot
Stress, craving and mood as predictors of early dropout from opioid agonist therapy
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2020.108333openalex-snapshot
Longitudinal patterns of cocaine use among patients receiving injectable hydromorphone or diacetylmorphine for the treatment of opioid use disorder: A growth curve modeling approach
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2020.108466openalex-snapshot
Factors associated with early and later dropout from methadone maintenance treatment in specialist addiction clinics: a six-year cohort study using proportional hazards frailty models for recurrent treatment episodes
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108528openalex-snapshot
Meaning and purpose in the context of opioid overdose deaths
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108703openalex-snapshot
Shorter outpatient wait-times for buprenorphine are associated with linkage to care post-hospital discharge
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108844openalex-snapshot
The relationship between crystal methamphetamine use and methadone retention in a prospective cohort of people who use drugs
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108849openalex-snapshot
Racial/ethnic disparities in the use of medications for opioid use disorder (MOUD) and their effects on residential drug treatment outcomes in the US
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.108907openalex-snapshot
Factors associated with obtaining employment among opioid use disorder patients enrolled in a therapeutic workplace intervention
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.109077openalex-snapshot
Associations between fentanyl use and initiation, persistence, and retention on medications for opioid use disorder among people living with uncontrolled HIV disease
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2021.109091openalex-snapshot
Using administrative data to predict cessation risk and identify novel predictors among new entrants to opioid agonist treatment
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109337openalex-snapshot
Short communication: Relationship between social determinants and opioid use disorder treatment outcomes by gender
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109498openalex-snapshot
Treatment outcomes associated with medications for opioid use disorder (MOUD) among criminal justice-referred admissions to residential treatment in the U.S., 2015–2018
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109507openalex-snapshot
Identifying key risk factors for premature discontinuation of opioid use disorder treatment in the United States: A predictive modeling study
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109521openalex-snapshot
Association between clinically recognized suicidality and subsequent initiation or continuation of medications for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109624openalex-snapshot
Predictors of crystal methamphetamine use initiation or re-initiation among people receiving opioid agonist therapy: A prospective cohort study
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109730openalex-snapshot
Discontinuation of opioid agonist treatment following release from prison in a cohort of men who injected drugs prior to imprisonment in Victoria, Australia: A discrete-time survival analysis
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109734openalex-snapshot
The effects of childhood trauma and mental disorders on treatment engagement, contact with the criminal justice system, and mortality among people with opioid dependence
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2022.109739openalex-snapshot
Exploring factors jointly associated with recurrent relapse and dropout of methadone maintenance treatment clients in Guangdong, China: A retrospective cohort study
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109839openalex-snapshot
Buprenorphine treatment receipt characteristics and retention among people who inject drugs at Integrated Care Centers in India
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109868openalex-snapshot
Duration of medication for opioid use disorder during pregnancy and postpartum by race/ethnicity: Results from 6 state Medicaid programs
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.109932openalex-snapshot
Opioid agonist therapy switching among individuals with prescription-type opioid use disorder: Secondary analysis of a pragmatic randomized trial
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.111036openalex-snapshot
Opioid agonist treatment in transition: A cross-country comparison between Austria, Germany and Switzerland
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2023.111051openalex-snapshot
Who receives heroin-assisted treatment? A comparison of patients receiving opioid maintenance treatment in Denmark
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.111368openalex-snapshot
Predictors of urine toxicology and other biologic specimen missingness in randomized trials of substance use disorders
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2024.112497openalex-snapshot
Does implementation of office based addiction treatment by a nurse care manager increase the duration of OUD treatment in primary care? A secondary analysis of the PROUD randomized control trial
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2025.112616openalex-snapshot
Evaluation of an in-jail and post-release comprehensive treatment model for opioid use disorder in Massachusetts
inferred← citeshttps://doi.org/10.1016/j.drugalcdep.2025.112708openalex-snapshot
Designer benzodiazepines: Availability, motives, and fatalities. A systematic narrative review of human studies
inferred← citeshttps://doi.org/10.1016/j.drugpo.2021.103503openalex-snapshot
Correlates of days of medication for opioid use disorder exposure among people living with HIV in Northern Vietnam
inferred← citeshttps://doi.org/10.1016/j.drugpo.2022.103709openalex-snapshot
Factors associated with 60-day adherence to “safer supply” opioids prescribed under British Columbia's interim clinical guidance for health care providers to support people who use drugs during COVID-19 and the ongoing overdose emergency
inferred← citeshttps://doi.org/10.1016/j.drugpo.2022.103879openalex-snapshot
Opioid agonist therapy engagement and crystal methamphetamine use: The impact of unregulated opioid use in Vancouver, Canada
inferred← citeshttps://doi.org/10.1016/j.drugpo.2022.103931openalex-snapshot
Multidimensional assessment of access to medications for opioid use disorder across urban and rural communities: A scoping review
inferred← citeshttps://doi.org/10.1016/j.drugpo.2023.104075openalex-snapshot
Impacts of the COVID-19 pandemic on enrollment in medications for opioid use disorder (MOUD) in Vancouver, Canada: An interrupted time series analysis
inferred← citeshttps://doi.org/10.1016/j.drugpo.2023.104187openalex-snapshot
Long-term patterns of treatment use for opioid use disorder (OUD): Findings from the 18-20-year Australian Treatment Outcome Study
inferred← citeshttps://doi.org/10.1016/j.drugpo.2024.104390openalex-snapshot
96-week retention in treatment with extended-release subcutaneous buprenorphine depot injections among people with opioid dependence: Extended follow-up after a single-arm trial
inferred← citeshttps://doi.org/10.1016/j.drugpo.2024.104420openalex-snapshot
Time for Australia to increase take away doses in opioid agonist treatment
inferred← citeshttps://doi.org/10.1016/j.drugpo.2024.104470openalex-snapshot
‘Matters-of-concern’ associated with discontinuation of long-acting injectable buprenorphine: Findings from a longitudinal qualitative study
inferred← citeshttps://doi.org/10.1016/j.drugpo.2026.105174openalex-snapshot
Optimal provision of opioid agonist therapy (OAT) and needle and syringe programmes (NSP): a realist evaluation
inferred← citeshttps://doi.org/10.1016/j.drugpo.2026.105437openalex-snapshot
Beyond one-size-fits-all: Latent patient classes at methadone treatment entry and their clinical implications – Evidence from a large real-world cohort
inferred← citeshttps://doi.org/10.1016/j.jadohealth.2024.07.013openalex-snapshot
A Scoping Review of Evidence-Based Interventions and Health-Related Services for Youth Who Use Nonmedical Opioids in Canada and the United States
inferred← citeshttps://doi.org/10.1016/j.josat.2023.208956openalex-snapshot
Crystal methamphetamine use and methadone maintenance treatment dissatisfaction: A prospective cohort study in Vancouver, Canada
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209012openalex-snapshot
Stimulant use among patients in opioid treatment settings: Provider perspectives
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209022openalex-snapshot
The Role of Health Plans in Addressing the Opioid Crisis: A Qualitative Study
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209036openalex-snapshot
Malmö Treatment Referral and Intervention Study (MATRIS)—36-month follow-up on retention and substance use among patients referred from needle exchange to opioid agonist treatment—The role of stimulant use at baseline
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209055openalex-snapshot
Transitioning off methadone: A qualitative study exploring why patients discontinue methadone treatment for opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209188openalex-snapshot
Gender differences in receipt of telehealth versus in person behavioral therapy, medication for opioid use disorder (MOUD), and 90-day MOUD retention during the pandemic: A retrospective veteran cohort study
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209217openalex-snapshot
Linkage facilitation services for opioid use disorder: Taxonomy of facilitation practitioners, goals, and activities
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209248openalex-snapshot
Expanding access to Medication for Opioid Use Disorder (MOUD) in jails: A comprehensive program evaluation
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209250openalex-snapshot
Clinical stakeholders' perceptions of patient engagement in outpatient medication treatment for opioid use disorder: A qualitative study
inferred← citeshttps://doi.org/10.1016/j.josat.2023.209271openalex-snapshot
Racial and ethnic disparities in medication for opioid use disorder access, use, and treatment outcomes in Medicare
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209441openalex-snapshot
Payment-related barriers to medications for opioid use disorder: A critical review of the literature and real-world application
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209449openalex-snapshot
Predictors of retention in heroin-assisted treatment in Denmark 2010–2018 – A record-linkage study
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209581openalex-snapshot
Patient experiences in outpatient substance use disorder treatment: A qualitative study exploring both clinical and non-clinical contexts
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209588openalex-snapshot
Treatment completion among Australians attending publicly-funded specialist alcohol and other drug treatment services
inferred← citeshttps://doi.org/10.1016/j.josat.2024.209616openalex-snapshot
“I still can feel the sickness”: Withdrawal experiences of people on methadone maintenance treatment
inferred← citeshttps://doi.org/10.1016/j.josat.2025.209686openalex-snapshot
Non-adherence to treatment and concurrent opioid use among people on methadone maintenance treatment using methamphetamine in Vietnam
inferred← citeshttps://doi.org/10.1016/j.josat.2025.209744openalex-snapshot
Evaluation of a primary care-based Medication for Opioid Use Disorder (MOUD) program in a fully-integrated federally qualified health center
inferred← citeshttps://doi.org/10.1016/j.josat.2025.209837openalex-snapshot
Retention among Medicaid beneficiaries in opioid treatment programs in California
inferred← citeshttps://doi.org/10.1016/j.jpsychires.2025.09.049openalex-snapshot
Trends in substance use over 31 years in a large methadone maintenance treatment (MMT) clinic in Israel
inferred← citeshttps://doi.org/10.1016/j.jsat.2020.108256openalex-snapshot
Supportive alternate site provision of buprenorphine: Overcoming barriers and improving patient outcomes
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108404openalex-snapshot
The cascade of care for opioid use disorder among youth in British Columbia, 2018
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108548openalex-snapshot
Associations of retention on buprenorphine for opioid use disorder with patient characteristics and models of care in the primary care setting
inferred← citeshttps://doi.org/10.1016/j.jsat.2021.108558openalex-snapshot
Baseline executive functions and receiving cognitive rehabilitation can predict treatment response in people with opioid use disorder
inferred← citeshttps://doi.org/10.1016/j.jsat.2022.108753openalex-snapshot
A cohort study examining the relationship among housing status, patient characteristics, and retention among individuals enrolled in low-barrier-to-treatment-access methadone maintenance treatment
inferred← citeshttps://doi.org/10.1016/j.jsat.2022.108776openalex-snapshot
Long-acting injectable buprenorphine for opioid use disorder: A systematic review of impact of use on social determinants of health
inferred← citeshttps://doi.org/10.1016/j.pbb.2024.173725openalex-snapshot
Preliminary investigation of the administration of biperiden to reduce relapses in individuals with cocaine/crack user disorder: A randomized controlled clinical trial
inferred← citeshttps://doi.org/10.1016/j.phrs.2023.106998openalex-snapshot
IUPHAR-review: The integration of classic psychedelics into current substance use disorder treatment models
inferred← citeshttps://doi.org/10.1016/j.psychres.2025.116621openalex-snapshot
‘Involuntary treatment’ for severe substance use disorders: Selected suggestions to move considerations from ideological to evidence-based perspectives
inferred← citeshttps://doi.org/10.1016/j.sapharm.2021.11.007openalex-snapshot
A prospective, multisite implementation-efficacy trial of a collaborative prescriber-pharmacist model of care for Medication Assisted Treatment for Opioid Dependence: Protocol for the EPIC-MATOD study
inferred← citeshttps://doi.org/10.1016/j.sapharm.2025.10.009openalex-snapshot
A multisite pilot type 2 hybrid implementation-effectiveness trial of a community pharmacist-led model of collaborative care for Medication Assisted Treatment for Opioid Dependence: outcomes of the EPIC-MATOD trial
inferred← citeshttps://doi.org/10.1016/j.socscimed.2022.115034openalex-snapshot
Individual, interpersonal, and neighborhood measures associated with opioid use stigma: Evidence from a nationally representative survey
inferred← citeshttps://doi.org/10.1016/j.ssmmh.2022.100151openalex-snapshot
Application of the COM-B model to patient barriers and facilitators of retention in medication treatment for opioid use disorder in rural Northeastern United States: A qualitative study
inferred← citeshttps://doi.org/10.1016/j.trsl.2021.03.006openalex-snapshot
At the intersection of sleep deficiency and opioid use: mechanisms and therapeutic opportunities
inferred← citeshttps://doi.org/10.1016/j.ypmed.2021.106729openalex-snapshot
Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings
inferred← citeshttps://doi.org/10.1016/s0140-6736(21)01251-4openalex-snapshot
HIV and overdoses: diversifying therapies for opioid use disorder
inferred← citeshttps://doi.org/10.1016/s2215-0366(23)00119-0openalex-snapshot
Increasing overdose deaths among Black Americans: a review of the literature
inferred← citeshttps://doi.org/10.1016/s2468-2667(23)00082-8openalex-snapshot
Mortality among individuals prescribed opioid-agonist therapy in Scotland, UK, 2011–20: a national retrospective cohort study
inferred← citeshttps://doi.org/10.1024/0939-5911/a000907openalex-snapshot
Reintegration of People with Substance Use Disorders into Working Life
inferred← citeshttps://doi.org/10.1080/00952990.2021.1963757openalex-snapshot
Transition from methadone to subcutaneous buprenorphine depot in patients with opioid use disorder in custodial setting – a case series
inferred← citeshttps://doi.org/10.1080/00952990.2025.2544660openalex-snapshot
Associations between COVID impact domains and time to buprenorphine treatment disengagement
inferred← citeshttps://doi.org/10.1080/00952990.2025.2571414openalex-snapshot
Racial and ethnic disparities in buprenorphine retention and treatment outcome in a longitudinal cohort of U.S. veterans with opioid use disorder
inferred← citeshttps://doi.org/10.1080/07347324.2026.2617255openalex-snapshot
Integrating Medication and Psychosocial Support for Addiction Recovery: A Study of Congress 60
inferred← citeshttps://doi.org/10.1080/07853890.2023.2171107openalex-snapshot
Prior authorization restrictions on medications for opioid use disorder: trends in state laws from 2005 to 2019
inferred← citeshttps://doi.org/10.1080/07853890.2025.2486585openalex-snapshot
Mindful moms: acceptability and impact of co-designed and digitally delivered video meditations for pregnant and parenting women with opioid use disorder
inferred← citeshttps://doi.org/10.1080/08897077.2021.1944957openalex-snapshot
Stigmatization of Medications for Opioid use Disorder in 12-Step Support Groups and Participant Responses
inferred← citeshttps://doi.org/10.1080/08897077.2022.2060446openalex-snapshot
Using Data Science to Improve Outcomes for Persons with Opioid use Disorder
inferred← citeshttps://doi.org/10.1080/08897077.2022.2095082openalex-snapshot
Patient-Centered Quality Measurement for Opioid Use Disorder: Development of a Taxonomy to Address Gaps in Research and Practice
inferred← citeshttps://doi.org/10.1080/09687637.2022.2040007openalex-snapshot
Implementing injectable opioid agonist treatment: a survey of professionals in the field of opioid use disorders
inferred← citeshttps://doi.org/10.1080/09687637.2025.2566011openalex-snapshot
‘Involuntary treatment’ for severe substance use disorders (SUDs). An overview of key issues, experiences and outcomes for consideration in policy development in Canada
inferred← citeshttps://doi.org/10.1080/10550887.2024.2315366openalex-snapshot
10-year retention of a comprehensive treatment model of buprenorphine for opioid use disorder
inferred← citeshttps://doi.org/10.1080/10826084.2024.2305799openalex-snapshot
Evaluation of an Educational Intervention Based on Theory of Planned Behavior to Reduce Suicidal Ideation and Attempts in Drug Addicts Receiving Methadone: A Quasi-Experimental Study
inferred← citeshttps://doi.org/10.1080/10826084.2025.2570496openalex-snapshot
Predictors of Retention in a Clinical Trial of a Fentanyl Overdose Prevention Intervention: Implications for Supporting Participants’ Retention in Harm Reduction Research
inferred← citeshttps://doi.org/10.1080/10826084.2025.2580518openalex-snapshot
U.S. Military Veteran Perspectives on Barriers and Facilitators to Medication Treatment for Opioid Use Disorder
inferred← citeshttps://doi.org/10.1080/10826084.2025.2586255openalex-snapshot
People Who Use Illegal Opioids Use of Methadone over Time, and What Characteristics Are Correlated with Staying in Methadone Maintenance Treatment
inferred← citeshttps://doi.org/10.1080/10826084.2025.2608777openalex-snapshot
Operationalizing Contingency Management to Improve Adherence and Retention in Methadone Treatment: A Scoping Review
inferred← citeshttps://doi.org/10.1080/10826084.2026.2651447openalex-snapshot
Sociodemographic Factors Associated with Opioid Agonist Treatment Receipt and Retention at an Integrated Safety-Net Health System
inferred← citeshttps://doi.org/10.1080/10826084.2026.2693054openalex-snapshot
Reasons for Discontinuation and Associated Factors in Opioid Agonist Treatment: A Community-Based Study from India
inferred← citeshttps://doi.org/10.1080/13543784.2023.2173062openalex-snapshot
Immunotherapeutic strategies for treating opioid use disorder and overdose
inferred← citeshttps://doi.org/10.1080/14656566.2025.2507124openalex-snapshot
Approved medications for opioid use disorder : current update
inferred← citeshttps://doi.org/10.1080/14659891.2023.2233098openalex-snapshot
A retrospective cohort study to assess the dropout rates and its predictors in Ho Chi Minh City’s methadone maintenance program using a stringent criterion
inferred← citeshttps://doi.org/10.1080/14737167.2022.2016396openalex-snapshot
Five-year budget impact of a prescription digital therapeutic for patients with opioid use disorder
inferred← citeshttps://doi.org/10.1080/15504263.2023.2295416openalex-snapshot
A Harm Reduction Framework for Integrated Treatment of Co-Occurring Opioid Use Disorder and Trauma-Related Disorders
inferred← citeshttps://doi.org/10.1080/16066359.2023.2189245openalex-snapshot
Recurrent event analysis for time to dropout of newly-enrolled MMT participants in Guangdong, China: a retrospective study using the Prentice-Williams-Peterson model
inferred← citeshttps://doi.org/10.1080/16066359.2025.2605955openalex-snapshot
Preexisting morbidity and 2-year treatment retention in opioid agonist treatment. A population-based data-linkage study in the Czech Republic
inferred← citeshttps://doi.org/10.1080/29973368.2026.2638583openalex-snapshot
Long-Term Treatment Retention Among Adolescents and Young Adults with Opioid Use Disorder: A Four-Year Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1089/tmj.2023.0044openalex-snapshot
Retention in Telehealth Treatment for Opioid Use Disorder Among Rural Populations: A Retrospective Cohort Study
inferred← citeshttps://doi.org/10.1089/whr.2023.0082openalex-snapshot
Baseline Characteristics and Postdischarge Outcomes by Medication for Opioid Use Disorder Status Among Women with Polysubstance Use in Residential Treatment
inferred← citeshttps://doi.org/10.1093/cid/ciaf352openalex-snapshot
The Hepatitis C Cascade of Care for Opioid Agonist Therapy Recipients in Australia
inferred← citeshttps://doi.org/10.1093/jamia/ocaf157openalex-snapshot
Predicting treatment retention in medication for opioid use disorder: a machine learning approach using NLP and LLM-derived clinical features
inferred← citeshttps://doi.org/10.1097/adm.0000000000000895openalex-snapshot
Characterizing the Clinical use of a Novel Video-assisted Dosing Protocol With Secure Medication Dispensers to Reduce Barriers to Opioid Treatment
inferred← citeshttps://doi.org/10.1097/adm.0000000000001009openalex-snapshot
Three-year Retention Rates With Office-based Treatment of Buprenorphine for Opioid Use Disorder in a Private Family Medicine Practice
inferred← citeshttps://doi.org/10.1097/adm.0000000000001079openalex-snapshot
Implementation of Telemedicine Delivery of Medications for Opioid Use Disorder in Pennsylvania Treatment Programs During COVID-19
inferred← citeshttps://doi.org/10.1097/adm.0000000000001092openalex-snapshot
Associations Between Inpatient Induction on Medications for Opioid Use Disorder and Postdischarge Medications for Opioid Use Disorder Adherence, Overdose, and Service Use
inferred← citeshttps://doi.org/10.1097/adm.0000000000001093openalex-snapshot
Treatment History and Interest in Injectable Opioid Agonist Treatment With Hydromorphone Among People Who Inject Drugs
inferred← citeshttps://doi.org/10.1097/adm.0000000000001122openalex-snapshot
Assessment of COVID-19–Driven Changes in an Integrated OBGYN-Addiction Treatment Clinic and Future Implications
inferred← citeshttps://doi.org/10.1097/adm.0000000000001154openalex-snapshot
The Howard Street Method: A Community Pharmacy-led Low Dose Overlap Buprenorphine Initiation Protocol for Individuals Using Fentanyl
inferred← citeshttps://doi.org/10.1097/adm.0000000000001578openalex-snapshot
A Randomized Pilot Trial of an Integrated Intervention Combining Computerized Behavioral Therapy and Recovery Coaching for People With Opioid Use Disorder: The OVERCOME Study
inferred← citeshttps://doi.org/10.1097/adm.0000000000001643openalex-snapshot
Testing the Efficacy of an Adaptive Approach to Delivering Psychosocial Interventions in Office-based Buprenorphine Treatment
inferred← citeshttps://doi.org/10.1097/adm.0000000000001694openalex-snapshot
Evaluating the Impact of Pharmacist-Based Models of Care on Treatment Retention Among Individuals With Opioid Use Disorder: A Systematic Review and Meta-Analysis
inferred← citeshttps://doi.org/10.1097/adm.0000000000001775openalex-snapshot
Treatment Discontinuation and Barriers and Facilitators to Retention Among Individuals Initiating Buprenorphine for Opioid Use Disorder: A Longitudinal Cohort Study
inferred← citeshttps://doi.org/10.1097/cxa.0000000000000265openalex-snapshot
Rapid Buprenorphine Microinduction with Overlapping Slow-Release Oral Morphine: A Case Report
inferred← citeshttps://doi.org/10.1097/jan.0000000000000497openalex-snapshot
“It's Like Your Whole Body Hates You”
inferred← citeshttps://doi.org/10.1111/1475-6773.14271openalex-snapshot
Simulated impact of mobile opioid treatment program units on increasing access to methadone for opioid use disorder
inferred← citeshttps://doi.org/10.1111/add.15394openalex-snapshot
Effectiveness of incentivised adherence and abstinence monitoring in buprenorphine maintenance: a pragmatic, randomised controlled trial
inferred← citeshttps://doi.org/10.1111/add.15514openalex-snapshot
The effect of person, treatment and prescriber characteristics on retention in opioid agonist treatment: a 15‐year retrospective cohort study
inferred← citeshttps://doi.org/10.1111/add.15574openalex-snapshot
Impact of treatment duration on mortality among Veterans with opioid use disorder in the United States Veterans Health Administration
inferred← citeshttps://doi.org/10.1111/add.15736openalex-snapshot
Modeling the population‐level impact of opioid agonist treatment on mortality among people accessing treatment between 2001 and 2020 in New South Wales, Australia
inferred← citeshttps://doi.org/10.1111/add.15862openalex-snapshot
Duration of use and outcomes among people with opioid use disorder initiating methadone and buprenorphine in Ontario: a population‐based propensity‐score matched cohort study
inferred← citeshttps://doi.org/10.1111/add.15954openalex-snapshot
Impact of fentanyl use on initiation and discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder: secondary analysis of a Canadian treatment trial
inferred← citeshttps://doi.org/10.1111/add.16096openalex-snapshot
Evaluation of the gap in delivery of opioid agonist therapy among individuals with opioid‐related health problems: a population‐based retrospective cohort study
inferred← citeshttps://doi.org/10.1111/add.16339openalex-snapshot
Effects of the Connections program on return‐to‐custody, mortality and treatment uptake among people with a history of opioid use: Retrospective cohort study in an Australian prison system
inferred← citeshttps://doi.org/10.1111/add.16587openalex-snapshot
Predictability of buprenorphine‐naloxone treatment retention: A multi‐site analysis combining electronic health records and machine learning
inferred← citeshttps://doi.org/10.1111/add.16659openalex-snapshot
Medications for opioid use disorder: Predictors of early discontinuation and reduction of overdose risk in US military veterans by medication type
inferred← citeshttps://doi.org/10.1111/add.16766openalex-snapshot
Extended‐release pharmacotherapies for substance use disorders in incarcerated populations: A systematic review
inferred← citeshttps://doi.org/10.1111/add.70008openalex-snapshot
State sequence analysis of daily methadone dispensing trajectories among individuals at United States opioid treatment programs before and following COVID‐19 onset
inferred← citeshttps://doi.org/10.1111/add.70325openalex-snapshot
Retention in opioid agonist treatment during pregnancy and variations according to treatment and maternal characteristics
inferred← citeshttps://doi.org/10.1111/add.70482openalex-snapshot
Barriers and facilitators to detoxification from opioid substitution treatment: A mixed‐methods systematic review
inferred← citeshttps://doi.org/10.1111/add.70521openalex-snapshot
Craving and personal functioning as mediators of extended‐release buprenorphine efficacy: A four‐way decomposition analysis from a randomised trial
inferred← citeshttps://doi.org/10.1111/add.70526openalex-snapshot
Overdose reversal through peer intervention: Findings from the naloxone prospective outcome research study (NalPORS) on the effectiveness of overdose response by people who use opioids in the United Kingdom and Sweden
inferred← citeshttps://doi.org/10.1111/add.70543openalex-snapshot
Real‐world comparative effects of slow‐release oral morphine vs. methadone on healthcare use for opioid use disorder: A population‐based target trial emulation
inferred← citeshttps://doi.org/10.1111/ajad.13268openalex-snapshot
Buprenorphine treatment retention and comorbidities among patients with opioid use disorder in a primary care setting
inferred← citeshttps://doi.org/10.1111/ajad.13326openalex-snapshot
Comprehensive analysis of discharge reasons from methadone outpatient treatment programs
inferred← citeshttps://doi.org/10.1111/ajad.13347openalex-snapshot
Treatment utilization and modality preference among veterans receiving outpatient substance use disorder treatment during a pandemic
inferred← citeshttps://doi.org/10.1111/ajad.13557openalex-snapshot
Cognitive processing therapy (CPT) versus individual drug counseling (IDC) for PTSD for veterans with opioid use disorder maintained on buprenorphine
inferred← citeshttps://doi.org/10.1111/ajad.13619openalex-snapshot
Impact of baseline methamphetamine/amphetamine use on discontinuation of methadone and buprenorphine/naloxone among people with prescription‐type opioid use disorder in Canada
inferred← citeshttps://doi.org/10.1111/ajad.13635openalex-snapshot
Opioid agonist treatment outcomes among individuals with a history of nonfatal overdose: Findings from a pragmatic, pan‐Canadian, randomized control trial
inferred← citeshttps://doi.org/10.1111/dar.13445openalex-snapshot
Substance of choice, impact of heroin or opium on treatment retention in a multicentre randomised controlled trial in Iran
inferred← citeshttps://doi.org/10.1111/dar.13745openalex-snapshot
‘I don't chase drugs as much anymore, and I'm not dead’: Client reported outcomes associated with safer opioid supply programs in Ontario, Canada
inferred← citeshttps://doi.org/10.1111/dar.13890openalex-snapshot
Assessment of treatment retention rates and predictors of retention on opioid agonist treatment among adolescents
inferred← citeshttps://doi.org/10.1111/dar.70062openalex-snapshot
Community Pharmacy‐Based Injectable Opioid Agonist Treatment: Findings From a Canadian Pilot Program
inferred← citeshttps://doi.org/10.1111/dar.70074openalex-snapshot
Barriers to Accessing Opioid Treatment in Rural Queensland: Perspectives From Consumers and Clinicians
inferred← citeshttps://doi.org/10.1111/dar.70096openalex-snapshot
Experiences of People Who Discontinue Long‐Acting Injectable Buprenorphine Treatment Recently Released From Prison in New South Wales, Australia
inferred← citeshttps://doi.org/10.1111/jnc.70165openalex-snapshot
Exploring the Gut and Oral Microbiomes in Psychoactive Substance Use: A Scoping Review of Clinical Studies
inferred← citeshttps://doi.org/10.1111/jnu.12858openalex-snapshot
The impact of nursing on health outcomes of people receiving medication for opioid use disorder: An integrative review
inferred← citeshttps://doi.org/10.1111/jrh.70084openalex-snapshot
Bridging the gaps: Rural recovery community centers and their role in addressing substance use disorders
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-067194openalex-snapshot
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation
inferred← citeshttps://doi.org/10.1136/bmjopen-2022-069857openalex-snapshot
Patients’ perceptions of self-administered dosing to opioid agonist treatment and other changes during the COVID-19 pandemic: a qualitative study
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-088617openalex-snapshot
Patient experience of opioid use disorder treatment medications: a systematic review of contemporary qualitative research
inferred← citeshttps://doi.org/10.1136/bmjopen-2024-090736openalex-snapshot
Investigating outcomes in a substance use treatment provider: a cross-sectional comparison of long-acting injectable buprenorphine and oral medication for opioid use disorder
inferred← citeshttps://doi.org/10.1159/000527826openalex-snapshot
Feasibility and Short-Term Effects of Low-Threshold Opioid Substitution Treatment during the COVID-19 Pandemic in Hamburg, Germany
inferred← citeshttps://doi.org/10.1176/appi.ajp.20220687openalex-snapshot
Flexible Buprenorphine/Naloxone Treatment Models: Safe and Effective in Reducing Opioid Use Among Persons With Prescription Opioid Use Disorder
inferred← citeshttps://doi.org/10.1177/00220426211044410openalex-snapshot
Court-Mandated Treatment Outcomes for Prescribed Opioid Use Disorder: A Gender Based Study
inferred← citeshttps://doi.org/10.1177/07067437231194385openalex-snapshot
The Association Between Self-Reported Anxiety and Retention in Opioid Agonist Therapy: Findings From a Canadian Pragmatic Trial
inferred← citeshttps://doi.org/10.1177/07067437231210796openalex-snapshot
Associations Between Buprenorphine\Naloxone and Methadone Treatment and non-Opioid Substance Use in Prescription-Type Opioid Use Disorder: Secondary Analyses From the OPTIMA Study: Associations entre le traitement avec la buprénorphine/naloxone et avec la méthadone et l'utilisation de substances…
inferred← citeshttps://doi.org/10.1177/08897077231167291openalex-snapshot
A National Study of Homelessness, Social Determinants of Health, and Treatment Engagement Among Outpatient Medication for Opioid Use Disorder-Seeking Individuals in the United States
inferred← citeshttps://doi.org/10.1177/08897077231186218openalex-snapshot
Associations Between Patient-Reported Experiences with Opioid Use Disorder Treatment and Unmet Treatment Needs and Discontinuation Among Virginia Medicaid Members
inferred← citeshttps://doi.org/10.1177/10398562241295872openalex-snapshot
Effectiveness of long-acting buprenorphine – A systematic review
inferred← citeshttps://doi.org/10.1177/10775595261453528openalex-snapshot
Associations Between Medication for Opioid Use Disorder and Family Functioning in Child Welfare-Involved Families
showing the first 200 of 295
Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.